EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics

Jessica R Pickett, Yuao Wu, Lucia F Zacchi, Hang T Ta iD

Cardiovascular Research · 24.10.2023 · 119 (13) · 2278-2293

DOI: 10.1093/cvr/cvad130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 18.08.2023. Verfasst von Jessica R Pickett und 3 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Micro- and Nanotechnology Centre (QMNC), Griffith University, West Creek Road, Nathan, QLD 4111, Australia. Hauptthemen laut MEDLINE: Vascular Cell Adhesion Molecule-1, Atherosclerosis. Die Arbeit wurde bisher 153-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian National Health and Medical Research Council, National Heart Foundation of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular cell adhesion molecule-1 (VCAM-1) has been well established as a critical contributor to atherosclerosis and consequently as an attractive therapeutic target for anti-atherosclerotic drug candidates. Many publications have demonstrated that disrupting the VCAM-1 function blocks monocyte infiltration into the sub-endothelial space, which effectively prevents macrophage maturation and foam cell transformation necessary for atherosclerotic lesion formation. Currently, most VCAM-1-inhibiting drug candidates in pre-clinical and clinical testing do not directly target VCAM-1 itself but rather down-regulate its expression by inhibiting upstream cytokines and transcriptional regulators. However, the pleiotropic nature of these regulators within innate immunity means that optimizing dosage to a level that suppresses pathological activity while preserving normal physiological function is extremely challenging and oftentimes infeasible. In recent years, highly specific pharmacological strategies that selectively inhibit VCAM-1 function have emerged, particularly peptide- and antibody-based novel therapeutics. Studies in such VCAM-1–directed therapies so far remain scarce and are limited by the constraints of current experimental atherosclerosis models in accurately representing the complex pathophysiology of the disease. This has prompted the need for a comprehensive review that recounts the evolution of VCAM-1–directed pharmaceuticals and addresses the current challenges in novel anti-atherosclerotic drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Cell Adhesion Molecule-1AtherosclerosisHumansEndothelium, VascularMonocytesDrug DiscoveryCell Adhesion

Stichwörter der Autor:innen

Anti-VCAM-1 therapyAtherosclerosisCardiovascular diseaseInflammationVCAM-1

Substanzen

Vascular Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Queensland Micro- and Nanotechnology Centre (QMNC), Griffith University, West Creek Road, Nathan, QLD 4111, Australia.
  • School of Environment and Science, Griffith University, Kessels Road, Nathan, QLD 4111, Australia.
  • Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, St. Lucia, QLD 4072, Australia.
  • School of Chemistry and Molecular Biosciences, the University of Queensland, St. Lucia, QLD 4072, Australia.

ORCID-Profile: Hang T Ta

Förderung

  • Australian National Health and Medical Research Council
  • National Heart Foundation of Australia

Zitieren

APA

Pickett, J. R., Wu, Y., Zacchi, L. F., & Ta, H. T. (2023). Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics. Cardiovascular Research, 119(13), 2278-2293. https://doi.org/10.1093/cvr/cvad130

Vancouver

Pickett JR, Wu Y, Zacchi LF, Ta HT. Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics. Cardiovascular Research. 2023;119(13):2278-2293. doi:10.1093/cvr/cvad130

BibTeX
@article{Pickett2023,
  author = {Pickett, Jessica R and Wu, Yuao and Zacchi, Lucia F and Ta, Hang T},
  title = {Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {13},
  pages = {2278--2293},
  doi = {10.1093/cvr/cvad130}
}
Kostenlos starten →